Tandem Health Raises $100 Million Series B Led By EQT’s Scaleup Europe Fund
Article excerpt
Highlighted: the sentence this signal was extracted from
Tandem Health has raised $100 million in Series B funding led by the Scaleup Europe Fund managed by EQT, bringing the European healthcare AI company's total funding to $160 million. Existing investors Kinnevik, Northzone, Amino Collective and Visionaries also participated in the round. The financing follows Tandem's $50 million Series A in 2025 and represents the Scaleup Europe Fund's first investment in a healthcare AI company. Tandem plans to use the funding to accelerate the adoption of artificial intelligence across European healthcare, expand its presence in existing markets and evolve its product from an AI Medical Assistant into a broader AI-native Clinic Operating System. The company currently serves more than 10,000 care organizations across 14 European markets. Tandem's AI Medical Assistant supports clinicians before, during and after patient visits. The platform can prepare patient summaries ahead of appointments, provide clinical decision support during consultations and automate documentation, coding and task management afterward. The company's AI Scribe, Coding Assistant and Clinical Decision Support products have each been independently certified as Class IIa medical devices under the EU Medical Device Regulation. Tandem also holds certifications including ISO 27001, ISO 13485 and ISO 42001. Peer-reviewed research cited by Tandem found that clinicians using...
Keep reading with a free account
The rest of this article, and every signal for EQT, is in your free account.
